ABI-M201 in Adult Subjects With Mildly-to-Moderately Active Ulcerative Colitis
Public ClinicalTrials.gov record NCT03923478. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase 1b Study to Evaluate the Safety, Efficacy and Mircobiological Response of Oral ABI-M201 in Subjects With Mildly-to-Moderately Active UC With Ongoing Mesalamine Treatment
Study identification
- NCT ID
- NCT03923478
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Assembly Biosciences
- Industry
- Enrollment
- 15 participants
Conditions and interventions
Interventions
- ABI-M201 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 23, 2019
- Primary completion
- Jan 19, 2021
- Completion
- Jan 19, 2021
- Last update posted
- Mar 18, 2021
2019 – 2021
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| (Investigator site) | Oakland | California | 94612 | — |
| (Investigator Site) | San Carlos | California | 94070 | — |
| (Investigator Site) | Decatur | Georgia | 30033 | — |
| (Investigator Site) | Shreveport | Louisiana | 71105 | — |
| (Investigator Site) | Chesterfield | Michigan | 48047 | — |
| (Investigator Site) | Ypsilanti | Michigan | 48197 | — |
| (Investigator Site) | Rochester | Minnesota | 55905 | — |
| (Investigator Site) | Jackson | Tennessee | 38305 | — |
| (Investigator Site) | Bellevue | Washington | 98004 | — |
| (Investigator Site) | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03923478, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 18, 2021 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03923478 live on ClinicalTrials.gov.